Company & Sponsor Intelligence

University of California, Los Angeles

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials49

Recruiting10

Completed34

Countries2

Therapeutic footprint

adhdalzheimersanxietyautismbipolar_disorderdepressionepilepsyintellectual_disabilityneurodevelopmental_otherother_neurologyother_psychiatryptsdspinal_cord_injurystrokesubstance_use

Indexed studies

NCT00569829Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School Settings
anxiety · PHASE2

NCT06874790RCT for Latina Mental Health Using Web-Based Apps
depression · United StatesNA

NCT01784263Schema, Emotion, and Behavior Therapy for Children
autism · United StatesNA

NCT03153371Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
alzheimers · United StatesCOMPLETED

NCT01561105Improving Depression Care for Elders: Coordinating Center
depression · NA

NCT06218056Cannabidiol for Reducing Cigarette Use
other_psychiatry · United StatesPHASE2

NCT04883463Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
spinal_cord_injury · United StatesNA

NCT01082237Biomarkers for Outcomes In Late-life Depression (BOLD)
depression · United StatesPHASE4

NCT04553263Relapse Prevention in Stimulant Use Disorder
adhd · United StatesEARLY_PHASE1

NCT03117530Measuring Brain Inflammation in Autism
autism · United StatesPHASE1

NCT02010086Schema, Emotion and Behavior-Based Therapy for School Children
autism · United StatesNA

NCT03870737Four-week Open-trial Extension TNS for ADHD
adhd · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →